Article Information
History
- June 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aleksandra Kovacevic1,2,*,
- Rosalind M. Eggo3,
- Marc Baguelin4,5,
- Matthieu Domenech de Cellès6 and
- Lulla Opatowski1,2
- 1Epidemiology and Modelling of Antibiotic Evasion Unit, Institut Pasteur, 25 rue du docteur Roux, Paris 75015, France
- 2Anti-infective Evasion and Pharmacoepidemiology Team, CESP, Université Paris-Saclay, UVSQ, INSERM U1018 Montigny-le-Bretonneux, France
- 3Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London. WC1E 7HT UK
- 4Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
- 5MRC Centre for Global Infectious Disease Analysis and the Department of Infectious Disease Epidemiology, Imperial College London, London, UK
- 6Max Planck Institute for Infection Biology, Infectious Disease Epidemiology group, Charitéplatz 1, Campus Charité Mitte, 10117 Berlin, Germany
- ↵*Corresponding author
: Aleksandra Kovacevic, Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion Unit, 25, rue du Docteur Roux, 75015 Paris, e-mail: aleksandra.kovacevic{at}pasteur.fr
Posted June 12, 2021.
The impact of co-circulating pathogens on SARS-CoV-2/COVID-19 surveillance: How concurrent epidemics may decrease true SARS-CoV-2 percent positivity
